NEW YORK, May 26, 2021 /PRNewswire/ -- Bruderman Brothers, LLC ("Bruderman Brothers"), is pleased to announce the successful sale of HealthEx Corporation ("HealthEx") to Associated Courier, Inc. ("ACI ...
12d
A Look At SELLAS Life Sciences Group (SLS) Valuation After New IMPACT AML Clinical Study Agreement
SELLAS Life Sciences Group (SLS) has entered an agreement with IMPACT-AML, a pan-European clinical network, to run a new study of its CDK9 inhibitor SLS009 in high-risk newly diagnosed acute myeloid ...
Detailed price information for Sellas Life Sciences Group Inc (SLS-Q) from The Globe and Mail including charting and trades.
The average one-year price target for SELLAS Life Sciences Group (NASDAQ:SLS) has been revised to 7.14 / share. This is an increase of 16.67% from the prior estimate of 6.12 dated October 31, 2023.
Fintel reports that on September 7, 2023, Cantor Fitzgerald reiterated coverage of SELLAS Life Sciences Group (NASDAQ:SLS) with a Overweight recommendation. As of August 31, 2023, the average one-year ...
SELLAS Life Sciences Group recently reported that its Phase 3 REGAL trial of galinpepimut‑S (GPS) in Acute Myeloid Leukemia had reached 72 of the 80 overall-survival events required for final analysis ...
SELLAS Life Sciences Group Inc. Times Square Tower 7 Times Square Suite 2503 New York, New York 10026 Phone1 646 200-5278 IndustryBiotechnology SectorHealth Care/Life Sciences Fiscal Year-end12/2024 ...
NORTHBROOK, Ill.--(BUSINESS WIRE)--M. Holland Company, a leading distributor of thermoplastic resins and 3D printing materials, announced its 3D Printing group has partnered with Advanced Laser ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results